DUODART is indicated for treatment of benign prostatic hyperplasia (BPH) with moderate to severe symptoms. It reduces the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education